Cargando…
TIGIT enhances CD4(+) regulatory T‐cell response and mediates immune suppression in a murine ovarian cancer model
Ovarian cancer (OC) is the fifth‐leading cause of cancer‐related death in women with a pathogenesis involving activation of regulatory T cells (Tregs). The T‐cell immunoglobulin and ITIM domain (TIGIT) is a well‐known immune checkpoint molecule that inhibits T‐cell responses. However, the role of TI...
Autores principales: | Chen, Fengzhen, Xu, Yanying, Chen, Yulong, Shan, Shu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221438/ https://www.ncbi.nlm.nih.gov/pubmed/32212317 http://dx.doi.org/10.1002/cam4.2976 |
Ejemplares similares
-
Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axis
por: Ozmadenci, Duygu, et al.
Publicado: (2022) -
TIGIT blockade repolarizes AML-associated TIGIT(+) M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis
por: Brauneck, Franziska, et al.
Publicado: (2022) -
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
por: Sumi, Natalia J., et al.
Publicado: (2014) -
Mechanisms of TIGIT-driven immune suppression in cancer
por: Kurtulus, Sema, et al.
Publicado: (2014) -
TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer
por: Maas, Ralph Ja, et al.
Publicado: (2020)